Resources
Filter by Topic
- Press Releases
NorstellaLinQ dataset achieves highest scores on data quality for claims backbone real-world data (RWD) use cases and is now available to Atropos Evidence Network members
- Publication
By Sumit Verma, Mike Blecker, Thomas Edwards, Meg Richards, Shreekant V. Parasuraman, Evan M. Braunstein, Pankit Vachhani
- Case Study
Fill out the form below to download the case study.
- Booklets
Volume 5: A Collection of Recent Regulatory Decisions Based on RWE
- Press Releases
NorstellaLinQ integrates 74 billion connected data points, paving the way for breakthroughs in drug development and commercialization
- Blogs
A Q&A with Panalgo’s General Manager, Kevin D’Ambrosia
- eBook
Preeclampsia is a life-threatening form of hypertension that occurs during pregnancy – and the cases are on the rise in the US.
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
September 28, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined
RWE: Supporting Regulatory Submissions with Real-World Evidence
In this article with HIT Consultant, Tiffany Siu Woodworth, Director of Analytics Solutions at Panalgo, discusses RWE within the regulatory landscape. She notes how in
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Click here for the publication.
Podium and Posters from ICPE 2021
PODIUM PRESENTATION: Predictors of Severe COVID-19 Outcomes in Patients with Rheumatoid Arthritis Presented by Sara Burns SPOTLIGHT POSTER: Factors Associated with Initiation of Oral vs.
Leveraging RWD in Observational Studies: Understanding the Implications of Time-Related Biases
Dr. Suissa spoke at Panalgo’s 2021 IHD User conference about the implications of relying on observational studies that may have time-related biases and how to
Innovating RWE Organizations: Learning from the Past and Looking to the Future
Chris spoke at Panalgo’s 2021 IHD User conference about the evolution of Real-World Evidence (RWE) and how pharma needs to reimagine its function – to
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization